# Phase II/III of Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Healthy Children Aged 5-11

> **NCT04591405** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Institute of Medical Biology, Chinese Academy of Medical Sciences** · enrollment: 11999 (actual)

## Conditions studied

- Epidemic Parotitis, Mumps

## Interventions

- **BIOLOGICAL:** Attenuated Mumps vaccine (KMB-17) in phase II and III
- **BIOLOGICAL:** Placebo in phase II
- **BIOLOGICAL:** Attenuated Mumps vaccine (KMB-17) in phase III
- **BIOLOGICAL:** Placebo in phase III

## Key facts

- **NCT ID:** NCT04591405
- **Lead sponsor:** Institute of Medical Biology, Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-10-12
- **Primary completion:** 2024-07-01
- **Final completion:** 2024-07-01
- **Target enrollment:** 11999 (ACTUAL)
- **Last updated:** 2023-10-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04591405

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04591405, "Phase II/III of Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Healthy Children Aged 5-11". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT04591405. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*